EREG
Proepiregulin
Also known as: ER, EREG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14944
- Gene
- EREG
- Ensembl
- ENSG00000124882
- Chromosome
- 4
- Canonical length
- 169 aa
- Protein class
- Human disease related genes, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Vesicles,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a secreted peptide hormone and member of the epidermal growth factor (EGF) family of proteins. The encoded protein is a ligand of the epidermal growth factor receptor (EGFR) and the structurally related erb-b2 receptor tyrosine kinase 4 (ERBB4). The encoded protein may be involved in a wide range of biological processes including inflammation, wound healing, oocyte maturation, and cell proliferation. Additionally, the encoded protein may promote the progression of cancers of various human tissues. [provided by RefSeq, Jul 2015]
Canonical amino-acid sequenceUniProt
169 residues, UniProt reviewed canonical sequence.
>O14944|EREG
1 MTAGRRMEML CAGRVPALLL CLGFHLLQAV LSTTVIPSCI PGESSDNCTA LVQTEDNPRV
61 AQVSITKCSS DMNGYCLHGQ CIYLVDMSQN YCRCEVGYTG VRCEHFFLTV HQPLSKEYVA
121 LTVILIILFL ITVVGSTYYF CRWYRNRKSK EPKKEYERVT SGDPELPQVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EREG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 122 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 122 nTPM
- esophagus: 12 nTPM
- appendix: 9.6 nTPM
- skin: 8.8 nTPM
- gallbladder: 5.2 nTPM
- urinary bladder: 4.6 nTPM
Single-cell type
- monocytes: 3,369 nCPM
- monocyte progenitors: 3,243 nCPM
- megakaryocyte-erythroid progenitors: 1,195 nCPM
- hematopoietic stem cells: 948 nCPM
- megakaryocyte progenitors: 935 nCPM
- esophageal apical cells: 833 nCPM
Immune cell
- eosinophil: 0.5 nTPM
- basophil: 0.4 nTPM
- classical monocyte: 0.2 nTPM
- intermediate monocyte: 0.2 nTPM
- myeloid DC: 0.2 nTPM
- neutrophil: 0.1 nTPM
Brain region
- thalamus: 1.7 nTPM
- pons: 1.4 nTPM
- cerebral cortex: 1.3 nTPM
- choroid plexus: 1.3 nTPM
- hippocampal formation: 1.2 nTPM
- hypothalamus: 1.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.57
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.37
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- angiogenesis
- animal organ morphogenesis
- cell-cell signaling
- cytokine-mediated signaling pathway
- epidermal growth factor receptor signaling pathway
- ERBB2-EGFR signaling pathway
- ERBB2-ERBB4 signaling pathway
- ERBB4-ERBB4 signaling pathway
- female meiotic nuclear division
- keratinocyte differentiation
- keratinocyte proliferation
- luteinizing hormone signaling pathway
- mRNA transcription
- negative regulation of cell population proliferation
- negative regulation of DNA-templated transcription
- negative regulation of epithelial cell proliferation
- negative regulation of smooth muscle cell differentiation
- oocyte maturation
- ovarian cumulus expansion
- ovulation
- positive regulation of cell division
- positive regulation of cell population proliferation
- positive regulation of cytokine production
- positive regulation of DNA replication
- positive regulation of fibroblast proliferation
- positive regulation of innate immune response
- positive regulation of interleukin-6 production
- positive regulation of mitotic nuclear division
- positive regulation of phosphorylation
- positive regulation of protein kinase activity
- positive regulation of smooth muscle cell proliferation
- primary follicle stage
- response to peptide hormone
- wound healing
Molecular functions
- epidermal growth factor receptor binding
- growth factor activity
- receptor ligand activity
- transmembrane receptor protein tyrosine kinase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EREG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EREG as an antibody target. Whether an autoantibody or antibody against EREG could matter depends on whether native EREG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EREG is annotated at the cell surface, where native EREG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EREG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...